SpectronRx
  • Sign In

  • My Account

  • My Account
SpectronRx
  • Home
  • COVID
    • Radionuclides
    • Contract Manufacturing
    • Regulatory Solutions
    • Library
    • Downloads & Videos
    • SpectronRx BLOG
    • Employee Portal
    • Management Team
    • Dedication to Quality
    • News & Events
    • Careers
  • Contact
    • Home
    • COVID
    • Contract Manufacturing
      • Radionuclides
      • Contract Manufacturing
      • Regulatory Solutions
    • Resources
      • Library
      • Downloads & Videos
      • SpectronRx BLOG
      • Employee Portal
    • About Us
      • Management Team
      • Dedication to Quality
      • News & Events
      • Careers
    • Contact
  • Sign In

  • My Account

  • My Account

Signed in as:

filler@godaddy.com

  • Home
  • COVID
  • Contact

Account


  • My Account

  • Sign In
  • My Account
Hello

Welcome TO OUR LIBRARY

There's much to see here. We are sharing "hot", recent publications in the field of theranostics. So, take your time, look around, and learn. We hope you enjoy our library. More to come!

Lutetium

image229

Current Status of 177 Lu-PSMA Targeted Therapies and Where Will We Be In the Near Future

image230

ESMO 2019: Preliminary Results of a Phase I/II Dose-escalation Study of Fractionated Dose 177Lu-PSMA-617 for Progressive mCRPC

image231

Phase I/II Trial of Lutetium-177–PSMA-617 Plus Idronoxil in Metastatic Castration-Resistant Prostate Cancer

image232

PSMA PET During Lu-177–PSMA Radioligand Therapy May Help Guide Treatment

image233

Results of a 50 patient single-center phase II prospective trial of Lutetium-177 PSMA-617 theranostics in metastatic castrate-resistant prostate cancer

Actinium

image234

225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study

Find out more
image235

Advances in targeted alpha therapy for prostate cancer

Find out more
image236

225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience

Find out more
image237

Clinical Experience on 225Ac-PSMA-617 Targeted Alpha Therapy in Metastatic Castration Resistant Prostate Cancer Patients: Safety and Efficacy Results

Find out more
image238

Safety and Efficacy of Ac-225-PSMA-617 in mCRPC after Failure of Lu-177-PSMA

Find out more

IODINE

image239

Iodine Symporter Targeting with 124I/131I Theranostics

image240

¹³¹I-Metaiodobenzylguanidine Theranostics in Neuroblastoma: Historical Perspectives; Practical Applications

image241

MIBG in Neuroblastoma Diagnostic Imaging and Therapy.

ZIRCONIUM

image242

Zirconium-89 Labeled Antibodies: A New Tool for Molecular Imaging in Cancer Patients

Find out more
image243

Pharmacokinetics, Biodistribution, and Radiation Dosimetry for 89Zr-Trastuzumab in Patients with Esophagogastric Cancer

Find out more
image244

Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?

Find out more
image245

89Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art 89Zr Radiochemistry

Find out more

Thank you for visiting our Library.

Knowledge is important in our business, we strive for the highest level of excellence in our business, service, and competencies. Feel free to reach out if you want more information.

Find out more

Copyright © 2021 SpectronRx - All Rights Reserved.